Evidence map›Paper›PMID 28540295›Full record

ArticleBioMed research international2017

Relaxin Attenuates Contrast-Induced Human Proximal Tubular Epithelial Cell Apoptosis by Activation of the PI3K/Akt Signaling Pathway In Vitro.

Xiang-Cheng Xie, Yizhi Cao, Xiu Yang, Qun-Hong Xu, Wei Wei, Ming Wang

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Mechanism ofFrontiers in nephrology · 2022
    Review
  6. Article
  7. Review
  8. Total Flavonoids fromEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
  9. Analysis ofBioMed research international · 2018
    Article
  10. Extracts ofFrontiers in pharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiang-Cheng XieDepartment of Nephrology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang, China.
Yizhi CaoDepartment of Pathophysiology, Nanjing Medical University, Nanjing, Jiangsu, China.
Xiu YangDepartment of Nephrology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang, China.
Qun-Hong XuDepartment of Nephrology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang, China.
Wei WeiDepartment of Nephrology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang, China.
Ming WangDepartment of Nephrology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, Zhejiang, China.ORCID 0000-0001-5789-623X
Hangzhou First People's Hospital · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Kidney InjuryApoptosisbcl-2-Associated X ProteinCaspase 3Cell LineCell SurvivalChromonesEpithelial CellsGene Expression RegulationHumansIatrogenic DiseaseKidney Tubules, ProximalMorpholinesPhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-aktRelaxin2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-onebcl-2-Associated X ProteinCASP3 protein, humanCaspase 3ChromonesioversolMorpholinesPhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-aktRelaxinTriiodobenzoic Acids

Identifiers

PMID28540295
PMCPMC5429925
OpenAlexW2608690864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.